The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 133, Issue , 2014, Pages 55-64

  Gandara L ^a   Sandes, E ^b   Di Venosa, G ^a   Prack Mc Cormick, B ^b   Rodriguez, L ^a   Mamone, L ^a   Batlle, A ^a   Eijan A M ^b   Casas, A ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b Instituto de Oncologia Angel H Roffo   (Argentina)

Author keywords

ALA; Aminolevulinic acid; Combination; Photodynamic Therapy; Silibinin; Silybin

Indexed keywords

AMINOLEVULINIC ACID; FLAVONOID; PROTOPORPHYRIN; SILIBININ; PHOTOSENSITIZING AGENT; SILYMARIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CARCINOMA CELL; CELL CULTURE; CELL DEATH; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LD 50; LETHAL DOSE; MASS ACTION; METASTASIS; MIGRATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SILYBUM MARIANUM; TREATMENT RESPONSE; CELL MOTION; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; LIGHT; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY; TOXICITY; TUMOR CELL LINE; URINARY BLADDER NEOPLASMS;

AMINOLEVULINIC ACID; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLAVONOIDS; HUMANS; LIGHT; MILK THISTLE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SILYMARIN; URINARY BLADDER NEOPLASMS;

EID: 84897496876     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2014.03.006     Document Type: Article

References (62)

1. T.J. Dougherty, J.E. Kaufman, A. Goldfarb, K.R. Weishaupt, D. Boyle, and A. Mittleman Photoradiation therapy for the treatment of malignant tumors Cancer Res. 38 1978 2628 2635 (Pubitemid 8390848)
2. P. Agostinis, K. Berg, K.A. Cengel, T.H. Foster, A.W. Girotti, S.O. Gollnick, S.M. Hahn, M.R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B.C. Wilson, and J. Golab Photodynamic therapy of cancer: an update CA Cancer J. Clin. 61 2011 250 281
3. H.I. Pass Photodynamic therapy in oncology: mechanisms and clinical use J. Natl Cancer Inst. 85 1993 443 456 (Pubitemid 23084089)
4. M.F. Zuluaga, and N. Lange Combination of photodynamic therapy with anti-cancer agents Curr. Med. Chem. 15 2008 1655 1673
5. R.S. Svatek, A.M. Kamat, and C.P. Dinney Novel therapeutics for patients with non-muscle-invasive bladder cancer Expert Rev. Anticancer Ther. 9 2009 807 813
6. S.G. Kimani, J.B. Phillips, J.I. Bruce, A.J. MacRobert, and J.P. Golding Antioxidant inhibitors potentiate the cytotoxicity of photodynamic therapy Photochem. Photobiol. 88 2012 175 187
7. B. Chen, B. Ahmed, W. Landuyt, Y. Ni, R. Gaspar, T. Roskams, and P.A. de Witte Potentiation of photodynamic therapy with hypericin by mitomycin C in the radiation-induced fibrosarcoma-1 mouse tumor model Photochem. Photobiol. 78 2003 278 282
8. A. Casas, H. Fukuda, and A.M. Batlle Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide Cancer Biochem. Biophys. 16 1998 183 196 (Pubitemid 128701530)
9. I. Tsujino, K. Miyagi, R.W. Sampson, and F. Sieber Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B Photochem. Photobiol. 82 2006 458 465
10. B. Kosharskyy, N. Solban, S.K. Chang, I. Rizvi, Y. Chang, and T. Hasan A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer Cancer Res. 66 2006 10953 10958 (Pubitemid 44876994)
11. C.L. Saw, P.W. Heng, and M. Olivo Potentiation of the photodynamic action of hypericin J. Environ. Pathol. Toxicol. Oncol.: Off. Organ Int. Soc. Environ. Toxicol. Cancer 27 2008 23 33 (Pubitemid 351507420)
12. J. Kleban, J. Mikes, B. Szilardiova, J. Koval, V. Sackova, P. Solar, V. Horvath, J. Hofmanova, A. Kozubik, and P. Fedorocko Modulation of hypericin photodynamic therapy by pretreatment with 12 various inhibitors of arachidonic acid metabolism in colon adenocarcinoma HT-29 cells Photochem. Photobiol. 83 2007 1174 1185 (Pubitemid 47438512)
13. R.P. Singh, G. Deep, M. Chittezhath, M. Kaur, L.D. Dwyer-Nield, A.M. Malkinson, and R. Agarwal Effect of silibinin on the growth and progression of primary lung tumors in mice J. Natl Cancer Inst. 98 2006 846 855 (Pubitemid 43923441)
14. G. Deep, and R. Agarwal Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer Cancer Metast. Rev. 29 2010 447 463
15. L. Li, J. Zeng, Y. Gao, and D. He Targeting silibinin in the antiproliferative pathway Expert Opin. Investig. Drugs 19 2010 243 255
16. C.W. Cheung, N. Gibbons, D.W. Johnson, and D.L. Nicol Silibinin-a promising new treatment for cancer Anti-Cancer Agents Med. Chem. 10 2010 186 195
17. S. Bousserouel, G. Bour, H. Kauntz, F. Gosse, J. Marescaux, and F. Raul Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway Anticancer Res. 32 2012 2455 2462
18. H. Kauntz, S. Bousserouel, F. Gosse, and F. Raul Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells Apoptosis: Int. J. Program. Cell Death 16 2011 1042 1053
19. D. Nambiar, V. Prajapati, R. Agarwal, and R.P. Singh In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells Cancer Lett. 2012
20. Y. Yu, S.M. Fan, S.J. Yuan, S. Tashiro, S. Onodera, and T. Ikejima Nitric oxide (NO) generation but not ROS plays a major role in silibinin-induced autophagic and apoptotic death in human epidermoid carcinoma A431 cells Free Radical Res. 46 2012 1346 1360
21. H.R. Chang, P.N. Chen, S.F. Yang, Y.S. Sun, S.W. Wu, T.W. Hung, J.D. Lian, S.C. Chu, and Y.S. Hsieh Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel Mol. Carcinog. 50 2011 811 823
22. M.Z. Dizaji, M. Malehmir, A. Ghavamzadeh, K. Alimoghaddam, and S.H. Ghaffari Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line Neurochem. Res. 37 2012 370 380
23. S. Mateen, K. Raina, C. Agarwal, D. Chan, and R. Agarwal Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells J. Pharmacol. Exp. Ther. 345 2013 206 214
24. S.J. Oh, S.P. Jung, J. Han, S. Kim, J.S. Kim, S.J. Nam, J.E. Lee, and J.H. Kim Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells Oncol. Rep. 29 2013 1343 1348
25. C.M. Lin, Y.H. Chen, H.P. Ma, B.W. Wang, J.H. Chiu, S.K. Chua, J.R. Ong, and K.G. Shyu Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro J. Agric. Food Chem. 60 2012 12451 12457
26. E.O. Sandes, C. Lodillinskym, Y.V. Langle, A.R. Casabé, and A.M. Eiján Efectos del flavonoide silimarina solo o combinado con BCG en líneas de cáncer de vejiga humana T24 y murina MB49 Med. Basi. Assoc. 68 2008 169
27. B. Prack, A.M. Eiján, and E.O. Sandes El flavonoide silibina mejora el efecto antitumoral de la radioterapia sobre células de cáncer de vejiga humano Med. Basi. Assoc. 71 2011 102
28. S. Shahzidi, B. Cunderlikova, A. Wiedlocha, Y. Zhen, V. Vasovic, J.M. Nesland, and Q. Peng Simultaneously targeting mitochondria and endoplasmic reticulum by photodynamic therapy induces apoptosis in human lymphoma cells Photochem. Photobiol. Sci.: Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol. 10 2011 1773 1782
29. D. Grebenova, K. Kuzelova, K. Smetana, M. Pluskalova, H. Cajthamlova, I. Marinov, O. Fuchs, J. Soucek, P. Jarolim, and Z. Hrkal Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells J. Photochem. Photobiol. B Biol. 69 2003 71 85 (Pubitemid 36336463)
30. A. Casas, H. Fukuda, G. Di Venosa, and A. Batlle Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy Br. J. Cancer 85 2001 279 284 (Pubitemid 32695752)
31. A.C. Moor Signaling pathways in cell death and survival after photodynamic therapy J. Photochem. Photobiol. B Biol. 57 2000 1 13
32. I. Cecic, and M. Korbelik Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors Cancer Lett. 183 2002 43 51 (Pubitemid 34607350)
33. A. Casas, G. Di Venosa, S. Vanzulli, C. Perotti, L. Mamome, L. Rodriguez, M. Simian, A. Juarranz, O. Pontiggia, T. Hasan, and A. Batlle Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy Cancer Lett. 271 2008 342 351
34. N. Etminan, C. Peters, J. Ficnar, S. Anlasik, E. Bunemann, P.J. Slotty, D. Hanggi, H.J. Steiger, R.V. Sorg, and W. Stummer Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment Lab. Invest. J. Neurosurg. 115 2011 281 288
35. M. Wagner, E.R. Suarez, T.R. Theodoro, C.D. Machado Filho, M.F. Gama, J.P. Tardivo, F.M. Paschoal, and M.A. Pinhal Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases Clin. Exp. Dermatol. 37 2012 527 533
36. M. Chakrabarti, N.L. Banik, and S.K. Ray Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo PLoS ONE 8 2013 e55652
37. K. Raina, and R. Agarwal Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms Acta Pharmacol. Sin. 28 2007 1466 1475 (Pubitemid 47366688)
38. D. Shan, L. Chen, J.T. Njardarson, C. Gaul, X. Ma, S.J. Danishefsky, and X.Y. Huang Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice Proc. Nat. Acad. Sci. USA 102 2005 3772 3776 (Pubitemid 40354687)
39. E. Sandes, C. Lodillinsky, R. Cwirenbaum, C. Arguelles, A. Casabe, and A.M. Eijan Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guerin in transitional cancer cell lines Int. J. Mol. Med. 20 2007 823 828
40. I.S. Cogno, N.B. Vittar, M.J. Lamberti, and V.A. Rivarola Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells J. Photochem. Photobiol. B, Biol. 104 2011 434 443
41. C. Reynolds, and B. Maurer Evaluating response to antineoplastic drug combinations in tissue culture models, methods in molecular medicine, vol. 110: chemosensitivity: vol. 1 R.D. Blumenthal, In Vitro Assays 2005 Humana Press Inc. Totowa, NJ
42. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
43. C. Sridar, T.C. Goosen, U.M. Kent, J.A. Williams, and P.F. Hollenberg Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases Drug Metab. Dispos.: Biol. Fate Chem. 32 2004 587 594 (Pubitemid 38668150)
44. C. Soto, R. Mena, J. Luna, M. Cerbon, E. Larrieta, P. Vital, E. Uria, M. Sanchez, R. Recoba, H. Barron, L. Favari, and A. Lara Silymarin induces recovery of pancreatic function after alloxan damage in rats Life Sci. 75 2004 2167 2180 (Pubitemid 39120024)
45. G. Muzes, G. Deak, I. Lang, K. Nekam, V. Niederland, and J. Feher Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol) Orv. Hetil. 131 1990 863 866
46. M.C. Comelli, U. Mengs, C. Schneider, and M. Prosdocimi Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy Integr. Cancer Ther. 6 2007 120 129 (Pubitemid 46871849)
47. K. Raina, C. Agarwal, R. Wadhwa, N.J. Serkova, and R. Agarwal Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries Autophagy 9 2013 697 713
48. S. Zhang, Y. Yang, Z. Liang, W. Duan, J. Yang, J. Yan, N. Wang, W. Feng, M. Ding, Y. Nie, and Z. Jin Silybin-mediated inhibition of notch signaling exerts antitumor activity in human hepatocellular carcinoma cells PLoS ONE 8 2013 e83699
49. S. Dhanalakshmi, G.U. Mallikarjuna, R.P. Singh, and R. Agarwal Dual efficacy of silibinin in protecting or enhancing ultraviolet B radiation-caused apoptosis in HaCaT human immortalized keratinocytes Carcinogenesis 25 2004 99 106 (Pubitemid 38128622)
50. D. Kessel Death pathways associated with photodynamic therapy Med. Laser Appl.: Int. J. Laser Treat. Res. 21 2006 219 224 (Pubitemid 44636438)
51. A.K. Tyagi, C. Agarwal, D.C. Chan, and R. Agarwal Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells Oncol. Rep. 11 2004 493 499
52. G. Di Venosa, L. Rodriguez, L. Mamone, L. Gandara, M.V. Rossetti, A. Batlle, and A. Casas Changes in actin and E-cadherin expression induced by 5-aminolevulinic acid photodynamic therapy in normal and Ras-transfected human mammary cell lines J. Photochem. Photobiol. B, Biol. 106 2012 47 52
53. A. Costa, A. Scholer-Dahirel, F. Mechta-Grigoriou, The role of reactive oxygen species and metabolism on cancer cells and their microenvironment, Seminars in cancer biology, 2014.
54. J. Wang, and J. Yi Cancer cell killing via ROS: to increase or decrease, that is the question Cancer Biol. Ther. 7 2008 1875 1884
55. T.W. Flaig, L.J. Su, G. Harrison, R. Agarwal, and L.M. Glode Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells Int. J. Cancer 120 2007 2028 2033 (Pubitemid 46418384)
56. S. Pesakhov, M. Khanin, G.P. Studzinski, and M. Danilenko Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells Nutr. Cancer 62 2010 811 824
57. A. Dagne, T. Melkamu, M.M. Schutten, X. Qian, P. Upadhyaya, X. Luo, and F. Kassie Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice Carcinogenesis 32 2011 561 567
58. C.J. Gomer, A. Ferrario, and A.L. Murphree The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis Br. J. Cancer 56 1987 27 32 (Pubitemid 17097693)
59. S. Schreiber, S. Gross, A. Brandis, A. Harmelin, V. Rosenbach-Belkin, A. Scherz, and Y. Salomon Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery Int. J. Cancer 99 2002 279 285 (Pubitemid 34309487)
60. I.O. Lisnjak, V.V. Kutsenok, L.Z. Polyschuk, O.B. Gorobets, and N.F. Gamaleia Effect of photodynamic therapy on tumor angiogenesis and metastasis in mice bearing Lewis lung carcinoma Exp. Oncol. 27 2005 333 335 (Pubitemid 43139368)
61. N. Rousset, V. Vonarx, S. Eleouet, J. Carre, E. Kerninon, Y. Lajat, and T. Patrice Effects of photodynamic therapy on adhesion molecules and metastasis J. Photochem. Photobiol., B, Biol. 52 1999 65 73 (Pubitemid 30011497)
62. A. Casas, F. Sanz-Rodriguez, G. Di Venosa, L. Rodriguez, L. Mamone, A. Blazquez, P. Jaen, A. Batlle, J.C. Stockert, and A. Juarranz Disorganisation of cytoskeleton in cells resistant to photodynamic treatment with decreased metastatic phenotype Cancer Lett. 270 2008 56 65